Beijing Sunbio Biotech Co. Ltd.

International Business Machines Corporation

Beijing Goldwind Science & Creation Windpower Equipment Co., Ltd.

Bing Zhu

Wei Sun

Xiaoyan Zhang

Haitao Xu

Jun Qian

Shifang Yang

Junsheng Cui

Peng Wei

Yuliang Liu

Yaqi Gu

Fanhu Meng

The disclosure relates to a mounting frame, an energy storage unit, a pitch system, a wind turbine and a method. The mounting frame for mounting accumulators in a hub includes: a base having a predetermined thickness, wherein the base includes a mounting surface in a thickness direction of the base; and two or more accumulator mounting elements disposed on the mounting surface at intervals, wherein each accumulator mounting element includes a supporting assembly and a holding assembly connected to the supporting assembly, the supporting assembly is connected to the mounting surface and extends in the thickness direction, and the holding assembly is adapted to clamp and fix the accumulator such that all the accumulators in the hub are mounted to the mounting frame.

Mounting frame, energy storage unit, pitch system, wind turbine and method

A pitch varying device, a pitch varying method and a pitch varying control device for a wind turbine blade and a wind turbine are provided. The blade pitch varying device includes: a disc-type driving structure perpendicular to an axis of a pitch bearing, a track surrounding the axis of the pitch bearing being provided on the disc-type driving structure; a first linear telescopic driving mechanism connected to the track through a first clamping member capable of clamping the track, and the first linear telescopic driving mechanism and the first clamping member being connected through a hinge connection; and a second linear telescopic driving mechanism connected to the track through a second clamping member capable of clamping the track, and the second linear telescopic driving mechanism and the second clamping member being connected through a hinge connection.

Pitch varying device, pitch varying method and pitch varying control device for wind turbine blade and wind turbine

Disclosed is a method of activating a mobile terminal from mobile network side and a mobile application gateway system. The method comprises: receiving, by a mobile application gateway, a request for activating the mobile terminal, the request including an unique identification number of the mobile terminal; querying, by the mobile application gateway, a HLR for address of a SGSN where the mobile terminal is located; returning, by the HLR, the queried address of SGSN to the mobile application gateway; sending, by the mobile application gateway, the request for activating the mobile terminal to the SGSN; issuing, by the SGSN, a request to the mobile terminal, requiring the mobile terminal to issue a mobile terminal initiated PDP context activation request. The method enables an instant messaging user at a mobile terminal to automatically open an IP connection if there is any message to be received after the IP connection is closed.

Activating a mobile terminal from mobile network side

Provided is a fusion protein comprising circularly permuted form of TRAIL, and the fusion protein contains circularly permuted form of TRAIL and oligopeptides located at the N-terminus and/or C-terminus of the permuted form. The oligopeptides contain a repeating sequence consisting of 3-10 histidines. The components of the circularly permuted form of TRAIL from N-terminus to C-terminus are: (a) amino acids 135-281 of TRAIL, (b) a linker, and (c) amino acids 121-135 of TRAIL or amino acids 114-135 of TRAIL or amino acids 95-135 of TRAIL or any fragments of amino acids 95-135 of TRAIL containing amino acids 121-135 of TRAIL. Also provided is a method for treating cancer by using the fusion protein.

Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof

The present invention provides a fusion protein comprising an immunostimulatory polypeptide and a mutant E7 protein of a human papilloma virus. The present invention also provides a gene encoding the fusion protein, expression vectors containing the gene, a pharmaceutical composition comprising the fusion protein, a method for treating or preventing a human papilloma virus related disease by using the fusion protein and uses of the fusion protein in the preparation of a medicament for the treatment or prevention of the human papilloma virus related disease.

HPV antigen fusion protein vaccine compositions and uses thereof

The present invention discloses a recombinant protein having an anti-cancer effect, its encoding gene and uses thereof. The recombinant protein having an anti-cancer effect provided by the present invention is one selected from the group consisting of: 1) a protein having the amino acid sequence of SEQ ID No:2 shown in the sequence listing; 2) a protein derived from SEQ ID No:2, which has a sequence homology of more than 90% with SEQ ID No:2 and which has the same activity as that of SEQ ID No:2; 3) a protein derived from SEQ ID No:2, which is obtained by adding or deleting 15 or less amino acid residues at the N-terminus of the amino acid sequence of SEQ ID No:2, and which has the same activity as that of SEQ ID No:2; 4) a protein derived from SEQ ID No:2, which is obtained by adding or deleting 15 or less amino acid residues at the C-terminus of the amino acid sequence of SEQ ID No:2, and which has the same activity as that of SEQ ID No:2; 5) a protein derived from SEQ ID No:2, which is obtained by substitution, deletion, or addition of one or several amino acid residues in the amino acid sequence of SEQ ID No:2, and which has the same activity as that of SEQ ID No:2. The medicament containing above recombinant protein as active component has significant selective inhibitory effect on tumor cells, and does not induce apoptosis of normal tissue cells, and has important applicable value.

Growing community of inventors

Beijing, China

Bing Zhu